MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 221 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,256 | -82.1% | 5,343 | -78.3% | 0.00% | -80.0% |
| Q1 2024 | $213,811 | +435.3% | 24,661 | +304.4% | 0.01% | – |
| Q4 2023 | $39,942 | -73.4% | 6,098 | -59.4% | 0.00% | -100.0% |
| Q3 2023 | $150,340 | +305.2% | 15,034 | +403.7% | 0.01% | +400.0% |
| Q2 2023 | $37,103 | +52904.3% | 2,985 | -40.3% | 0.00% | -50.0% |
| Q1 2023 | $70 | +133.3% | 4,999 | +134.0% | 0.00% | +100.0% |
| Q4 2022 | $30 | -99.9% | 2,136 | +146.7% | 0.00% | – |
| Q3 2022 | $22,000 | -95.0% | 866 | -94.4% | 0.00% | -100.0% |
| Q2 2022 | $436,000 | +50.9% | 15,353 | +87.6% | 0.01% | +233.3% |
| Q1 2022 | $289,000 | +502.1% | 8,183 | +614.0% | 0.00% | +200.0% |
| Q4 2021 | $48,000 | -36.0% | 1,146 | -24.9% | 0.00% | -50.0% |
| Q3 2021 | $75,000 | -49.3% | 1,525 | -57.0% | 0.00% | -50.0% |
| Q2 2021 | $148,000 | +362.5% | 3,545 | +290.4% | 0.00% | +300.0% |
| Q1 2021 | $32,000 | – | 908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |